Delivery Order SPE2DR25D3301-SPE2DR26F19BY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,348.90 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL syringes on November 14, 2025, with completion expected by December 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract supports the procurement of this specialized pharmaceutical product for federal...
- The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Tezspire 210 mg/1.91 mL syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 8, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $12,348.90 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 ml syringes on November 13, 2025, with an ultimate completion date of December 5, 2025. This firm fixed-price delivery order, which was not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a $9,374.36 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Tezspire 210 mg/1.91 mL syringes. This is a firm fixed-price delivery order with an ultimate completion date of June 23, 2025, and represents a non-competitive set-aside contract. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $4,939.58 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL syringes on November 3, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of November 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,469.78 delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Tezspire 210 mg/1.91 mL syringes. This non-set-aside, firm fixed-price contract is scheduled for completion by December 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support...
- The Defense Logistics Agency awarded a $2,469.78 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Tezspire 210 mg/1.91 ml syringes. The contract, which carries an ultimate completion date of December 10, 2025, was competitively awarded with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $14,061.54 delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL syringes on October 29, 2025, with a completion date of November 20, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a $14,061.54 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Tezspire 210 mg/1.91 mL syringes. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The work will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a $28,123.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Tezspire 210 mg/1.91 mL syringes. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of October 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under a larger procurement vehicle...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F19BYDelivery Order
The Defense Logistics Agency awarded a $24,697.80 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Tezspire 210 mg/1.91 mL syringes. This firm fixed-price contract, with an ultimate completion date of December 29, 2025, represents a competitively awarded, non-set-aside procurement supporting federal medical supply requirements. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs and other federal healthcare systems worldwide. AmerisourceBergen's established portfolio with DLA encompasses specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains, positioning the company as a critical vendor for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.7k | 12/4/25 |